A Dose Escalation and Expansion Trial With BYON4228 Alone and in Combination in Patients With Advanced or Metastatic Solid Tumors
Clinical trial NCT06932952 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06932952
- Sponsor
- Byondis B.V.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-07
- Primary completion
- 2026-04-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.